Spyre Therapeutics, Inc.SYRENASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
93.11%
↑ 1144% above average
Average (9y)
-8.92%
Historical baseline
Range
High:93.11%
Low:-124.20%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 93.11% |
| 2023 | -85.64% |
| 2022 | 0.64% |
| 2021 | 33.97% |
| 2020 | 38.12% |
| 2019 | -14.99% |
| 2018 | -18.31% |
| 2017 | 18.75% |
| 2016 | -124.20% |
| 2015 | -30.67% |